Stock listing

Lang & Schwarz:A40NJT Kezar Life Sciences, Inc. Aktie

German listing (Lang & Schwarz) of Kezar Life Sciences, Inc. · home listing NASDAQ:KZR

Follow Kezar Life Sciences, Inc. into a list and get an email when it puts out news.

Kezar Life Sciences, Inc. logo
Ticker
Lang & Schwarz:A40NJT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All Kezar Life Sciences, Inc. news

Kezar Life Sciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 76 in all · newest Mar 12, 2026 · oldest 2019
Decks
8 decks · latest Nov 10, 2025

Where Kezar Life Sciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:KZR · Home listingNASDAQUnited StatesUSD
Lang & Schwarz:A40NJT · This pageLang & SchwarzGermanyEUR
LS Exchange:A40NJTLS ExchangeGermanyEUR
BOATS:KZRBOATSUnited StatesUSD
Tradegate:2KZ0TradegateGermanyEUR
Frankfurt:2KZ0FrankfurtGermanyEUR
gettex:2KZ0gettexGermanyEUR
Munich:2KZ0MunichGermanyEUR
Stuttgart:2KZ0StuttgartGermanyEUR

Decks

DeckKindSlidesDate
Technical Presentation (November 2025)Technical14 slidesNov 10, 2025
Technical Presentation (March 2025)Technical36 slidesMar 25, 2025
Technical Presentation (February 2025)Technical33 slidesFeb 27, 2025
Technical Presentation (2023)Technical11 slides2023
Investor Day (June 2022)Investor day27 slidesJun 27, 2022
Investor Day (November 2021)Investor day62 slidesNov 15, 2021
Technical Presentation (2020)Technical6 slides2020
Investor Presentation (October 2019)Investor deck21 slidesOct 3, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bihua Chen
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past)
Director · Jun 20, 2018 – Jun 25, 2018 · Past
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · Since at least Jun 25, 2019
Graham Cooper
Other companies: Beam Therapeutics Inc. (Director · Since at least Feb 5, 2020); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Applied Molecular Transport Inc (Director · Jun 4, 2020 – Jan 27, 2022 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Assembly Biosciences, Inc. (See Remarks · Mar 8, 2018 – Mar 29, 2019 · Past); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); Receptos Inc (Chief Financial Officer · May 8, 2013 – Aug 27, 2015 · Past); Geron Corporation (EVP, Bus Dev & CFO · Jan 5, 2012 – May 17, 2012 · Past); Orexigen Therapeutics Inc (CFO and Treasurer · Apr 25, 2007 – Jan 18, 2011 · Past)
Director · Since at least Jun 20, 2018
Michael Kauffman
Other companies: Kyntra Bio, Inc. (Director · Since at least Jun 4, 2025); Verastem, Inc. (President, Development · Since at least Nov 26, 2012); Adicet Bio, Inc. (Director · Nov 17, 2021 – Aug 21, 2024 · Past); Karyopharm Therapeutics Inc. (Director · Nov 5, 2013 – Feb 28, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jan 15, 2010 – Jun 6, 2013 · Past); Onyx Pharmaceuticals Inc (Chief Medical Officer · Nov 16, 2009 – Feb 9, 2010 · Past)
Director · Since at least Jun 20, 2018
Jean-Pierre Sommadossi
Other companies: Atea Pharmaceuticals, Inc. (Chairman & CEO, Atea Pharmaceuticals · Since at least Oct 29, 2020); ABG Acquisition I Corp (Director · Feb 16, 2021 – Mar 1, 2023 · Past); Idenix Pharmaceuticals Inc (President, CEO, Chairman, Director · Dec 31, 2005 – Feb 10, 2010 · Past)
Director · Jun 20, 2018 – Jun 28, 2021 · Past
Marc Belsky
Other companies: Five Prime Therapeutics Inc (Senior Vice President and CFO · Sep 17, 2013 – Feb 26, 2018 · Past); Cell Genesys Inc (VP Finance & CAO · Dec 1, 2006 – Oct 14, 2009 · Past)
Chief Financial Officer · Since at least Jun 20, 2018
Noreen Henig
Other companies: Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Lazard Growth Acquisition Corp I (Director · Feb 9, 2021 – Feb 9, 2021 · Past)
Chief Medical Officer · May 1, 2020 – Jul 24, 2023 · Past
Vassiliki Economides
Other companies: Gritstone bio, Inc. (EVP, CHIEF FINANCIAL OFFICER · Jun 23, 2021 – Apr 4, 2025 · Past)
SVP, Strategy & External Aff. · Mar 4, 2019 – Mar 29, 2021 · Past
Christopher J KirkCEO, Director · Since at least Jun 20, 2018
Courtney WallaceDirector · Since at least Dec 9, 2021
All 19 people
PersonSeat
Elizabeth GarnerDirector · Since at least Dec 18, 2019
Jason DingesDirector · Jun 20, 2018 – Jun 28, 2021 · Past
John Franklin FowlerDirector · Since at least Jun 20, 2018
Mark C SchillerChief Operating Officer · Since at least Jan 15, 2024
Micki KlearmanDirector · Since at least Jun 1, 2021
Nicholas Michael MordwinkinChief Business Officer · Jul 11, 2022 – Jan 7, 2024 · Past
Niti GoelChief Medical Officer · Jun 20, 2018 – Jan 6, 2019 · Past
Pichi Luo ChiangSVP, Corporate Controller · Since at least Apr 1, 2025
Zung Phuong ToChief Development Officer · Since at least Apr 1, 2025

Open People

Log in to ask 6ix AI your own questions about Kezar Life Sciences, Inc.